Competitive ABPP Target Validation Service

Confirm compound engagement, prioritize functional targets, and evaluate selectivity with activity-centric chemoproteomics.

Competitive ABPP helps confirm whether a small molecule functionally engages target proteins in complex biological samples. We combine compound pre-incubation, activity-based probe labeling, enrichment, LC-MS/MS, and quantitative target prioritization to support direct engagement evidence, selectivity review, and follow-up study design.

We built this service for drug discovery teams that need more than a protein expression profile. Instead of asking only which proteins change in abundance, Competitive ABPP asks which active proteins lose probe labeling after compound treatment.

That reduced labeling pattern can help identify proteins whose active sites are occupied or functionally blocked by your compound.

With our Competitive ABPP Target Validation Service, we help you evaluate:

Direct target engagement in complex proteomes
Functional activity changes, not only abundance changes
Candidate on-target and off-target proteins
Enzyme family selectivity patterns
Compound analog comparison
Follow-up validation priorities

Discuss Your Target View sample requirements

Competitive ABPP target validation service workflow with compound pre-incubation, activity-based probe labeling, enrichment, LC-MS/MS, and target prioritization.

Functional Validation Service Capabilities Workflow Demo Results Sample Data Analysis Method Selection Case Study FAQ References Disclaimer

Competitive ABPP for Functional Target Validation

Competitive activity-based protein profiling is a chemoproteomics method used to evaluate whether a compound competes with an activity-based probe for access to functional protein sites. In a typical experiment, we first expose the sample to your compound or vehicle control. We then add an activity-based probe that labels active proteins or defined reactive sites.

If your compound occupies or blocks the same functional site, the probe signal decreases for that protein. By comparing compound-treated samples with controls using LC-MS/MS, we can rank proteins that show compound-dependent competition.

This makes Competitive ABPP valuable for target validation because it links binding behavior with protein activity. It can help answer a practical question: "Is this compound engaging a functional protein site in the biological context that matters to my project?"

What Competitive ABPP Measures

Competitive ABPP measures changes in probe labeling. A protein with reduced probe signal after compound pre-incubation may represent a compound-engaged target, a pathway-adjacent off-target, or a member of a related enzyme family affected by the compound.

The result is not just a long protein list. We organize the data into a target prioritization framework that considers competition trend, quantitative consistency, biological annotation, and follow-up value.

How Probe Competition Indicates Target Engagement

The logic is straightforward:

Active proteins are labeled by an activity-based probe in the control sample.
Your compound is pre-incubated with the matched experimental sample.
If the compound competes with the probe, probe labeling decreases.
LC-MS/MS quantifies which proteins or probe-modified peptides show reduced signal.
The strongest and most consistent changes become higher-priority target candidates.

This approach is particularly useful for enzyme classes and reactive sites where probe chemistry is available or can be adapted.

When This Method Adds Value Over Expression Proteomics

Standard quantitative proteomics tells you which proteins increase or decrease in abundance after treatment. Competitive ABPP gives a different readout: whether active protein sites are accessible to the probe after compound exposure.

That distinction matters when protein abundance is unchanged but activity or site occupancy changes. It is also helpful when several related enzymes are present and you need to understand selectivity across a protein family.

Our Competitive ABPP Service Capabilities

We support Competitive ABPP projects from study design through data interpretation. Our team works with you to understand the compound, target hypothesis, biological model, and available probe strategy before selecting the most appropriate workflow.

We can configure the service for discovery-scale target deconvolution, focused target validation, enzyme family selectivity profiling, or compound analog comparison.

MODE 1

Discovery-Scale Target Deconvolution

For early-stage projects, we can use Competitive ABPP to search for compound-engaged proteins across a broader active proteome.

Probe-enriched protein list
Competed target candidates
Quantitative competition matrix
Protein family annotation
Candidate target ranking
Follow-up validation suggestions

MODE 2

Focused Target Validation

If you already have a target hypothesis, we can design a focused Competitive ABPP study around that target class.

Expected-target engagement review
Matched control design
Related target-class review
Follow-up candidate prioritization

MODE 3

Selectivity and Off-Target Profiling

Competitive ABPP can help reveal whether a compound affects only the expected target or also competes with probes across related enzymes.

Expected target engagement
Related family-member engagement
Broad probe competition patterns
Lower-confidence background changes
Targets that may need orthogonal validation

MODE 4

Probe Strategy and Assay Configuration

Probe selection is central to project success. Some projects can start with known class-selective probes. Others may require discussion of compound-derived probes, clickable handles, photoaffinity strategies, or orthogonal target-validation methods.

We help evaluate whether the compound and target class fit Competitive ABPP before samples are submitted.

Share your compound and target hypothesis with us, and we can help you determine whether Competitive ABPP is the right next step.

Workflow with QC Checkpoints

Our workflow combines the technical steps of Competitive ABPP with project management checkpoints, so you know what happens from sample submission to final reporting.

Study Design and Control Planning

We begin by defining the biological question, sample type, compound conditions, probe strategy, and comparison groups. Control planning is critical because target competition is interpreted relative to vehicle, untreated, or matched reference conditions.

QC checkpoint: We confirm sample grouping, compound solvent, concentration logic, replicate structure, and whether the probe is suitable for the expected target class.

Compound Pre-Incubation

Samples are pre-incubated with your compound before probe labeling. This allows the compound to occupy accessible protein sites before the activity-based probe is introduced.

QC checkpoint: We review compound solubility, solvent compatibility, sample condition, and whether the compound treatment design is appropriate for the biological model.

Activity-Based Probe Labeling

An activity-based probe is added to label accessible active proteins or reactive sites. In the control sample, the probe should label its intended protein class. In the compound-treated sample, reduced probe labeling can indicate competition.

QC checkpoint: We monitor labeling efficiency, background signal, and whether the probe produces a clear signal in the selected sample type.

Click Chemistry or Enrichment

Depending on the probe format, labeled proteins or peptides are captured through click chemistry, affinity enrichment, or a matched enrichment workflow. This step concentrates probe-labeled targets before LC-MS/MS.

QC checkpoint: We check enrichment specificity, sample recovery, and evidence of nonspecific carryover.

Protein Digestion and LC-MS/MS Acquisition

Enriched proteins are digested into peptides and analyzed by LC-MS/MS. Data acquisition may be configured for broad profiling, focused target classes, or deeper quantitative analysis depending on the project scope.

QC checkpoint: We review MS signal quality, peptide identification performance, run consistency, and missing-value patterns.

Quantitative Data Processing

We compare probe-labeled signals between compound-treated and control samples. Candidate targets are ranked based on signal reduction, replicate consistency, annotation, and fit to the study question.

QC checkpoint: We evaluate replicate agreement, statistical confidence, background filtering, and whether the target list is biologically interpretable.

Target Prioritization and Reporting

The final deliverable connects the experimental design to decision-ready outputs. We do not simply send raw tables; we provide a structured report that explains what the target list means and which candidates should be considered for follow-up.

QC checkpoint: We review target ranking, annotation completeness, visual outputs, and method notes before final delivery.

Vertical Competitive ABPP workflow with QC checkpoints from study design to LC-MS/MS reporting.

Demo Results and How We Help You Interpret Them

Competitive ABPP results are most useful when they are visual, ranked, and tied to next-step decisions. Depending on your study design, your report may include the following types of outputs.

Composite Competitive ABPP demo results with dose-dependent probe competition, target prioritization plot, engagement heatmap, and target table.

Competitive ABPP demo output panel

OUTPUT 1

Dose-Dependent Probe Competition

A dose-dependent probe competition result shows whether increasing compound exposure reduces probe labeling for a protein or band. A consistent decrease in probe signal across compound conditions supports compound competition at a probe-accessible site.

This output is useful when you need to compare compound concentrations or confirm that engagement follows a concentration-dependent pattern.

OUTPUT 2

Target Prioritization Plot

A prioritization plot ranks proteins by quantitative competition and confidence. Strong candidates usually show clear signal reduction and consistent behavior across replicates.

This output helps your team move from a broad detected-target list to a shorter set of candidates for follow-up validation.

OUTPUT 3

Engagement Heatmap

A heatmap can compare target engagement across compound concentrations, analogs, or biological conditions. This format is useful when your team wants to compare a small compound series.

Shared engagement patterns may suggest conserved target classes, while analog-specific patterns may guide structure-activity interpretation.

OUTPUT 4

Selectivity and Off-Target Profile

A selectivity matrix shows how your compound affects related proteins in the same enzyme family or probe-accessible target class.

A narrow pattern may support selectivity within the tested target class. A broader pattern may suggest additional family engagement or off-target activity that should be reviewed before advancing the compound.

OUTPUT 5

Functional Annotation Summary

We annotate prioritized targets by protein family, pathway, subcellular context, or functional category when supported by the data.

Annotation helps connect target engagement to a biological mechanism while keeping the interpretation grounded in the experimental evidence.

OUTPUT 6

QC and Replicate Consistency Summary

We include QC outputs to help your team judge whether the data are suitable for interpretation.

Consistent labeling, enrichment, and quantification support stronger confidence in the target ranking. Inconsistent signals are flagged so they are not overinterpreted.

OUTPUT 7

Report-Ready Target Table

The final table summarizes each candidate target with competition trend, confidence, annotation, and suggested follow-up.

This table is designed to help your project team decide which targets deserve orthogonal validation.

Sample Requirements and Project Preparation

Clear sample preparation reduces background noise and improves the chance of interpretable Competitive ABPP data. Because probe chemistry and enrichment depth vary by project, final input amounts should be confirmed before submission.

The following table gives practical starting points based on proteomics sample guidance and common LC-MS/MS project needs. Proteomics sample guidance emphasizes sample quality control, suitable input amounts, and careful handling for cells, tissues, fluids, and pure proteins.

Sample Type	Recommended Input	Container	Shipping	QC Checkpoints	Notes
Cultured cells	5 × 10⁶ to 1 × 10⁷ cells per condition	1.5 mL low-bind tubes or cryovials	Dry ice	Cell count, viability record, PBS wash, pellet consistency	Prepare enough material for controls and replicates.
Trace cell samples	200–5000 cells for trace DIA-style workflows, project-dependent	Low-bind tubes	Dry ice	Cell loss review, contamination check, feasibility review	Feasibility must be confirmed before starting.
General animal tissues	30–50 mg for trace DIA workflows; 100–200 mg preferred for broader workflows	Cryovials	Dry ice	Tissue integrity, blood removal, protein recovery	Remove non-target tissue and avoid repeated freeze-thaw cycles.
Hard animal tissues	200 mg for label-free/DIA; 300–500 mg when more material is needed	Cryovials	Dry ice	Homogenization feasibility, protein extraction	Bones, hair, and hard tissues may need special handling.
Plant tissues	100 mg for soft plant tissue; 2 g for hard plant tissue	Cryovials or centrifuge tubes	Dry ice	Tissue consistency, debris removal, rapid freezing	Roots, bark, branches, and seeds often need more material.
Plasma, serum, or cerebrospinal fluid	20 µL without high-abundance protein depletion; 50–100 µL with depletion	1.5 mL tubes	Dry ice	Hemolysis check, depletion plan if needed	EDTA and other additives should be disclosed.
Follicular fluid	100 µL for standard proteomics; 20 µL may be feasible for trace DIA	1.5 mL tubes	Dry ice	Volume, clarity, protein recovery	Avoid repeated freeze-thaw cycles.
Lymph, synovial fluid, puncture fluid, or ascites	3 mL for standard workflows; 1 mL may be feasible for trace DIA	Screw-cap tubes	Dry ice	Centrifugation record, clarity, protein recovery	Clarify any additives or pre-treatment.
Culture supernatant	10 mL for standard workflows; 5 mL may be feasible for trace DIA	Screw-cap tubes	Dry ice	Serum-free condition, debris removal, volume	Serum-free medium requirements should be discussed in advance.
Pure protein	150 µg for label-free/DIA; 300 µg when more material is needed	Low-bind tubes	Dry ice or cold pack, project-dependent	Buffer compatibility, concentration, purity	Urea-based buffer may be suitable for some proteomics workflows.
Test compound	>2 mg dry powder or a qualified stock solution when possible	Labeled compound vial	Stability-based	Solubility, solvent, molecular weight, storage condition	Provide structure, stock concentration, solvent, and known activity information.

General handling expectations:

Keep samples cold throughout preparation.
Flash-freeze samples when appropriate.
Store frozen samples at -80°C.
Ship frozen samples on dry ice.
Avoid repeated freeze-thaw cycles.
Label biological replicates clearly.
Declare toxic, corrosive, polymeric, surfactant-containing, or unusual sample components in advance.

Send us your sample type and compound format before submission, and we will help confirm the most suitable preparation plan.

Bioinformatics and Data Interpretation

Competitive ABPP generates quantitative proteomics data that must be filtered, annotated, and interpreted carefully. We organize the analysis so your team can move from raw signal changes to practical target decisions.

Minimum Data Deliverables

Raw data processing summary
Protein or peptide identification table
Quantitative competition matrix
Prioritized target list
Replicate and missingness summary
QC summary
Basic protein annotation
Method and parameter record
Report-ready figures

Target Ranking and Annotation

We rank candidates using evidence that may include signal reduction, replicate consistency, confidence metrics, protein family relevance, and fit to the compound's known biology.

For each candidate, the report can include:

Protein name and accession
Observed competition trend
Relative confidence category
Known or predicted function
Protein family information
Suggested follow-up experiment

Optional Functional and Pathway Add-Ons

If your project needs deeper interpretation, we can add functional annotation, pathway enrichment, protein family selectivity mapping, compound analog comparison, and target-class visualization.

These add-ons are useful when you need to connect Competitive ABPP results with a mechanism-of-action hypothesis or prioritize a shorter list for orthogonal validation.

Reusable Files and Parameter Records

We can provide reusable files such as XLSX, CSV, PDF reports, and high-resolution figures. When applicable, we also provide method notes and parameter records so your team can review how the target list was generated.

How to Choose Competitive ABPP vs Related Target-Validation Methods

Competitive ABPP is powerful, but it is not the only way to study target engagement. The best method depends on your compound, target class, sample type, and evidence needs.

Method	Primary Readout	Compound Modification	Activity-State Information	Sample Compatibility	Strengths	Limitations	Best Fit
Competitive ABPP	Reduced activity-probe labeling after compound pre-incubation	Often uses a class probe; custom probe strategy may be needed	Strong, because it focuses on active or probe-accessible sites	Lysates, cells, tissues, or fractions depending on probe and design	Direct functional-site evidence, target prioritization, selectivity profiling	Requires suitable probe chemistry and careful controls	Enzyme target validation, covalent inhibitor profiling, off-target review
Affinity pull-down	Physical enrichment of proteins binding a tagged or immobilized ligand	Usually requires ligand tagging or immobilization	Limited; binding may not reflect activity	Mostly lysates or extracts	Useful first-pass binder discovery	Tags or immobilization can alter binding; weak or transient interactions may be missed	Early target fishing when ligand modification is acceptable
Thermal proteome profiling	Protein stability shift after compound treatment	No compound modification required	Indirect; stability shift, not activity	Cells, lysates, or tissues depending on design	Useful for unmodified compounds and broad target engagement	Some binders show little thermal shift; interpretation may require follow-up	Label-free engagement mapping
DARTS / LiP-MS	Protease resistance or structural accessibility change	No compound modification required	Indirect structural readout	Usually lysates; design-dependent	Good orthogonal evidence for conformational changes	Not always target-class selective; can be sensitive to digestion conditions	Follow-up validation and structural sensitivity screening
Standard quantitative proteomics	Protein abundance change	No modification required	No direct activity-site readout	Broad sample compatibility	Useful for downstream pathway response	Does not prove direct binding or active-site engagement	Understanding treatment response after target validation

Solution Selection Strategy

Choose Competitive ABPP when you need functional-site evidence and want to evaluate whether a compound competes with a probe in a target class of interest.

Choose Equilibrium dialysis-MS binding when your key question is solution-phase binding of an unmodified compound.

Choose Target immobilization and LC-MS binding when immobilized-target capture is appropriate for your sample and compound.

Choose CE-MS Affinity Screening when you need a binding-focused screening option with low sample consumption.

Choose Native MS Fragment Screening when early fragment binding is the main goal.

Choose Ion Mobility MS when conformational or structural separation adds value to the binding question.

For many drug discovery programs, the strongest evidence comes from a staged strategy: use Competitive ABPP to prioritize functional targets, then apply orthogonal binding, structural, or biochemical assays to confirm the highest-value candidates.

Case Study: Prioritizing Functional Targets from Competitive ABPP Data

Background

Target identification can become difficult when a small molecule affects several proteins in a complex proteome. In a published Cell Chemical Biology study, researchers used competitive activity-based protein profiling to study 1,2,3-triazole ureas in Mycobacterium tuberculosis research.

The challenge was not only to detect compound-engaged proteins. The researchers also needed to understand which targets were more likely to explain the compound series' biological activity.

Source: Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling.

Methods

The researchers screened a library of serine hydrolase inhibitors and selected four compounds for deeper comparison: AA691, AA692, AA701, and AA702. They then used competitive ABPP to profile serine hydrolase targets affected by these compounds in the M. tuberculosis proteome.

The study combined several layers of evidence:

Phenotypic screening to identify active compounds
Competitive ABPP to profile inhibited serine hydrolase targets
Biochemical enzyme assays to test individual target inhibition
Computational docking to compare predicted binding modes
Morphological profiling to connect target activity with cell wall-related effects

This multi-step design helped the researchers avoid treating every detected protein as equally important.

Results

The study screened about 200 compounds and focused on four compounds that formed a structure-activity series. Competitive ABPP helped prioritize serine hydrolase targets associated with the active compounds.

In Figure 3, the researchers measured residual activity of individual serine hydrolases after incubation with the selected compounds. The targets included TesA, FbpA, Rv0183, and Fas.

Several observations are especially relevant for target validation:

AA691 and AA692 inhibited TesA in close stoichiometry, while AA701 and AA702 showed weaker relative inhibition.
The competitive ABP assay showed a similar inhibition pattern for FbpA.
Rv0183 activity was strongly impaired by all tested compounds, which helped separate broadly inhibited targets from targets that better tracked with the active compound pattern.
Fas was not significantly inhibited under the tested competitive ABP assay conditions, helping narrow the follow-up focus.

These observations show why Competitive ABPP is useful for target prioritization. A detected target is only the starting point. The more important question is whether target inhibition follows the compound activity pattern and supports a biologically meaningful mechanism.

Conclusion

This case shows how Competitive ABPP can support target prioritization in a complex proteome. By combining probe competition with enzyme-level validation and functional follow-up, the study moved from a broad target profile to a more useful interpretation of which targets were most relevant to the compound series.

For our customers, this is the practical value of Competitive ABPP: it helps turn target engagement data into a follow-up-ready decision framework.

Competitive ABPP case study showing inhibition profiles for serine hydrolase targets prioritized from mass spectrometry data.

Competitive ABPP can help move from detected targets to prioritized targets for follow-up validation.

FAQ

Frequently Asked Questions

Q: What is Competitive ABPP?

Competitive ABPP is a chemoproteomics method that compares activity-based probe labeling between compound-treated and control samples. Reduced probe labeling after compound pre-incubation can indicate target engagement or functional-site competition.

Q: How is Competitive ABPP different from standard ABPP?

Standard ABPP profiles active proteins or probe-accessible sites. Competitive ABPP adds a compound pre-incubation step, allowing us to observe which probe-labeled targets are competed by the compound.

Q: Do I need a custom activity-based probe?

Not always. Some projects can use known class-selective probes. Other projects may need a custom probe strategy or an orthogonal method if suitable probe chemistry is not available.

Q: Can Competitive ABPP evaluate non-covalent compounds?

It may be possible depending on target class, probe strategy, and compound behavior. Some non-covalent compounds can be studied through competition with a suitable probe, but project fit should be reviewed before launch.

Q: What controls are recommended?

Typical controls may include vehicle control, probe-only control, compound-treated samples, matched biological replicates, and concentration or analog comparisons when relevant.

Q: What sample types are compatible?

Potential sample types include cultured cells, cell lysates, tissues, biological fluids, fractions, pure proteins, and microbial samples. Compatibility depends on probe chemistry, sample quality, and project design.

Q: What will I receive in the final report?

The report can include a target list, competition matrix, QC summary, replicate summary, prioritized target table, annotation results, visual figures, and suggested follow-up experiments.

Q: When should I combine Competitive ABPP with another method?

Use orthogonal methods when you need additional evidence for binding, structural change, activity change, or biological function. Common combinations include Competitive ABPP plus biochemical assays, thermal profiling, pull-down, DARTS, LiP-MS, or binding MS.

Q: Can this workflow compare compound analogs?

Yes. If the study is designed for analog comparison, Competitive ABPP can help compare engagement patterns across related compounds and support structure-activity interpretation.

Q: What should I provide before project scoping?

Please provide compound structure, molecular weight, solvent, stock concentration, known activity information, target hypothesis if available, sample type, expected groups, and any handling restrictions.

References

Disclaimer

This service is intended for Research Use Only. It is not intended for diagnostic, therapeutic, clinical decision-making, or any direct medical application.

Start Your Competitive ABPP Inquiry

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.